By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catalent Pharma Solutions 

14 Schoolhouse Road

Somerset  New Jersey  08873  U.S.A.
Phone: 732-537-6200 Fax: n/a


SEARCH JOBS

About Catalent Biologics:

Catalent Biologics is a fast growing business within Catalent Pharma Solutions focused on providing innovative technologies and solutions to help more and better biologic treatments get to patients. The business includes our proprietary GPEx cell line engineering platform, our new state-of-the-art biomanufacturing facility in Madison, WI., and our market leading biologics analytical services in Kansas City and Research Triangle Park, NC. With the recent acquisition of Redwood Bioscience in Emeryville, CA, we have added the SMARTag Antibody Drug Conjugate technology, providing a next-generation ADC platform to our biologics customers. Leveraging our growing differentiated technology portfolio, world class manufacturing capability, and other integrated services across the Catalent network, Catalent Biologics is positioned to drive significant growth for Catalent.

Working for Catalent Biologics is an opportunity to join an entrepreneurial team that is building a new business. Catalent is aggressively growing in biologics, and is making significant investments in people and capabilities in this area. This is a unique opportunity to join a small, fast growing business, backed by a global public company. People joining our team will also have significant career development/progression opportunities as our business continues to grow and expand.


Key Statistics


Email: info@catalent.com
Ownership: Public

Web Site: Catalent
Employees:
Symbol: CTLT
 









Company News
Catalent (CTLT) Announces Fourth Quarter and Fiscal Year 2017 Earnings Conference Webcast 7/20/2017 11:04:16 AM
Catalent (CTLT) To Host Spray Drying Technology Symposium To Highlight Solubility And Bioavailability Solutions 5/25/2017 11:09:54 AM
Catalent (CTLT) To Showcase Expanded Formulation Toolkit And Innovative Delivery And Manufacturing Technologies At CPhI North America 5/11/2017 1:01:56 PM
Catalent (CTLT) Reports Third Quarter Fiscal Year 2017 Results 5/5/2017 6:55:57 AM
Catalent (CTLT) Announces Third Quarter Fiscal Year 2017 Earnings Conference Webcast 4/18/2017 10:19:25 AM
NEMUS Bioscience And Catalent (CTLT) To Advance NB1222 Into Human Dosage Formulation Development 3/3/2017 6:27:37 AM
Catalent (CTLT) Completes Accucaps Acquisition To Expand Softgel Development And Manufacturing Capabilities And Capacity 2/16/2017 6:24:27 AM
Catalent (CTLT) Reports Second Quarter Fiscal Year 2017 Results 2/7/2017 6:36:22 AM
Catalent (CTLT) Release: Company Announces Second Quarter Fiscal Year 2017 Earnings Conference Webcast 1/19/2017 8:03:37 AM
Catalent (CTLT) To Develop Softgel Capsules For Jupiter Orphan Therapeutics’s Leading Orphan Disease Candidates 1/9/2017 11:45:34 AM
12345678910...
//-->